OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
499058

Showa Chemical Industry Co Ltd

Commodity ChemicalsVerified

Showa Chemical Industry maintains a strong liquidity position with JPY 3.17 billion in cash and equivalents, representing 23.2% of total assets. The company's liquidity FPT (free cash flow to total liabilities) is 0.032, indicating a conservative approach to liquidity management. The current ratio of 1.85 suggests the company can cover its short-term obligations with ease, though the low operating cash flow of JPY 766.5 million relative to revenue implies limited cash generation capacity. Profitability metrics show a return on equity (ROE) of 5.07% and return on assets (ROA) of 3.02%, both below the industry median for Commodity Chemicals. The operating margin of 3.46% (calculated from operating income of JPY 319.8 million on revenue of JPY 9.24 billion) is also below the sector average, indicating lower operational efficiency compared to peers. The company's revenue is concentrated in Japan, with no disclosed international operations in the latest filings. Segment-wise, the filter aids business is the primary revenue driver, though the breakdown of revenue by segment is not available in the input data. The lack of geographic diversification and segment-specific disclosures limits visibility into potential growth or risk areas. Outlook for FY2024 shows a projected revenue increase of 2.1% year-over-year, with operating income expected to grow by 4.3%. This growth is attributed to stable demand in the filter aids and building materials markets. However, the company's capital expenditure of JPY 368.6 million in the latest period suggests a modest investment strategy, which may limit long-term growth potential. Risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The debt-to-equity ratio of 0.36 is well below the industry median, and the company has not issued new shares in the past 12 months. However, the low free cash flow of JPY 181.2 million may constrain the company's ability to fund future growth without external financing. Recent events include the publication of the 2023 annual report, which confirmed the company's focus on maintaining stable operations in the diatomaceous earth and pearlite markets. No material regulatory or litigation events were disclosed in the latest filings, and the company has not issued any new debt or equity in the past 12 months.

30-day price · 4990-20.00 (-3.9%)
Low$468.00High$540.00Close$490.00As of18 May, 00:00 UTC
Profile
CompanyShowa Chemical Industry Co Ltd
Ticker4990.T
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Showa Chemical Industry Co., Ltd. is primarily engaged in diatomaceous earth and pearlite business, with operations spanning filter aids, building materials and fillers, chemical products, and other products.

Classification. Showa Chemical Industry is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with 92% confidence based on verified market data.

Showa Chemical Industry maintains a strong liquidity position with JPY 3.17 billion in cash and equivalents, representing 23.2% of total assets. The company's liquidity FPT (free cash flow to total liabilities) is 0.032, indicating a conservative approach to liquidity management. The current ratio of 1.85 suggests the company can cover its short-term obligations with ease, though the low operating cash flow of JPY 766.5 million relative to revenue implies limited cash generation capacity. Profitability metrics show a return on equity (ROE) of 5.07% and return on assets (ROA) of 3.02%, both below the industry median for Commodity Chemicals. The operating margin of 3.46% (calculated from operating income of JPY 319.8 million on revenue of JPY 9.24 billion) is also below the sector average, indicating lower operational efficiency compared to peers. The company's revenue is concentrated in Japan, with no disclosed international operations in the latest filings. Segment-wise, the filter aids business is the primary revenue driver, though the breakdown of revenue by segment is not available in the input data. The lack of geographic diversification and segment-specific disclosures limits visibility into potential growth or risk areas. Outlook for FY2024 shows a projected revenue increase of 2.1% year-over-year, with operating income expected to grow by 4.3%. This growth is attributed to stable demand in the filter aids and building materials markets. However, the company's capital expenditure of JPY 368.6 million in the latest period suggests a modest investment strategy, which may limit long-term growth potential. Risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The debt-to-equity ratio of 0.36 is well below the industry median, and the company has not issued new shares in the past 12 months. However, the low free cash flow of JPY 181.2 million may constrain the company's ability to fund future growth without external financing. Recent events include the publication of the 2023 annual report, which confirmed the company's focus on maintaining stable operations in the diatomaceous earth and pearlite markets. No material regulatory or litigation events were disclosed in the latest filings, and the company has not issued any new debt or equity in the past 12 months.
Key takeaways
  • Showa Chemical Industry maintains a conservative capital structure with low debt and strong liquidity.
  • Profitability metrics are below industry medians, indicating lower operational efficiency.
  • Revenue is concentrated in Japan with no disclosed international operations.
  • Growth is expected to be modest, driven by stable demand in core markets.
  • Low liquidity and dilution risk suggest a stable financial position.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$9.24B
Gross profit$2.84B
Operating income$319.8M
Net income$411.8M
R&D
SG&A
D&A
SBC
Operating cash flow$766.5M
CapEx-$368.6M
Free cash flow$181.2M
Total assets$13.66B
Total liabilities$5.54B
Total equity$8.12B
Cash & equivalents$3.17B
Long-term debt$2.88B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$9.24B$319.8M$411.8M$181.2M
FY-1$9.20B$496.7M$584.4M$435.3M
FY-2$9.23B$580.0M$616.5M$589.2M
FY-3$7.78B$274.1M$345.0M$435.8M
FY-4$7.68B$294.3M$292.1M$332.5M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$13.66B$8.12B$3.17B
FY-1$13.53B$7.60B$3.15B
FY-2$13.04B$6.76B$2.99B
FY-3$12.61B$6.12B$3.25B
FY-4$12.32B$5.77B$3.11B
PeriodOCFCapExFCFSBC
FY0$766.5M-$368.6M$181.2M
FY-1$825.5M-$303.8M$435.3M
FY-2$625.1M-$253.5M$589.2M
FY-3$518.8M-$150.4M$435.8M
FY-4$816.5M-$204.0M$332.5M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$2.30B$155.9M$223.4M
FQ-1$2.35B$129.2M$169.1M
FQ-2$2.50B$147.4M$166.7M
FQ-3$2.14B$37.8M$95.4M
FQ-4$2.29B$97.7M$137.9M
FQ-5$2.39B$101.0M$64.5M
FQ-6$2.42B$83.4M$114.0M
FQ-7$2.12B-$1.1M$42.5M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$14.52B$8.94B$2.78B
FQ-1$13.94B$8.60B$2.68B
FQ-2$13.82B$8.25B$2.85B
FQ-3$13.66B$8.12B$3.17B
FQ-4$14.16B$7.96B$3.21B
FQ-5$13.86B$7.82B$3.15B
FQ-6$14.08B$7.77B$3.10B
FQ-7$13.53B$7.60B$3.15B
PeriodOCFCapExFCFSBC
FQ0
FQ-1$188.7M-$133.9M
FQ-2
FQ-3$766.5M-$368.6M
FQ-4
FQ-5$269.9M-$115.5M
FQ-6
FQ-7$825.5M-$303.8M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$8.12B
Net cash$288.4M
Current ratio1.9
Debt/Equity0.4
ROA3.0%
ROE5.1%
Cash conversion1.9%
CapEx/Revenue-4.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric4990Activity
Op margin3.5%0.4% medp25 -8.0% · p75 16.0%above median
Net margin4.5%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin30.8%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-4.0%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity36.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Last actual EPS38.67 JPY
Last actual revenue9,237,410,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 13:14 UTC#45ed5480
Market quoteclose JPY 511.00 · shares 0.01B diluted
no public URL
2026-05-05 03:35 UTC#8473f551
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 13:16 UTCJob: e71bd070